Chemo harmful to brain tissue – Dr. Gordon Comments
By Linda on Nov 13, 2010 in F.I.G.H.T., Toxins | comments(0)
Linda’s comment:…More proof that protecting or building the immune with the FIGHT protocol. I can not say enough about the importance of getting on a lifelong daily detox program….here is more proof….
Dr. Gordon’s Comment:
Since DCIS (Ductile Carcinoma in Situ) is just a premalignant condition, the odds are good that with my FIGHT program or the Kobayashi program, monitored annually or more often with blood tests like www.caprofile.net or www.testyourself.com. With the knowledge of the damage chemo is doing to say nothing of the damage from radiation, would you want to let the mammogram push you into all of this expensive and dangerous care of surgery, radiation and chemo with the added risk from breast implants that often develop painful capsule contraction?
People are not being told how few cases go on to full blown cancer over a ten year period following this common diagnosis.
The annual use of blood based cancer screening and follow up with simple health promoting program based on my FIGHT program makes far more sense.
Save your brain from chemo side effects.
Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com
Full article: http://www.friendsoffreedom.org/articles.php?command=show&ID=15117
Excerpt:
Chemotherapy destroys brain tissue, cognitive function
by Jonathan Benson, staff writer(NaturalNews) New research out of Indiana University adds to the growing list of harmful side effects caused by chemotherapy. According to scientists, the chemical cancer treatment destroys gray matter in the brain associated with cognitive function and memory.
Published in the journal Breast Cancer Research and Treatment, the study is the first of its kind to use brain imaging scans to verify the negative effects of chemotherapy on the brain. However, previous studies have already found that chemotherapy damages cognitive function, providing the basis for the popular term used to describe this condition known as “chemobrain”.
“These analyses…suggest an anatomic basis for the cognitive complaints and performance changes seen in patients,” explained Andrew Saykin, Psy.D., director of the Indiana University Center for Neuroimaging and researchers at the IU Simon Cancer Center. “Memory and executive functions like multi-tasking and processing speed are the most typically affected functions and these are handled by the brain regions where we detected gray matter changes.”
